Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Rechallenge With Nivolumab After Vemurafenib Treatment of Initially Nivolumab-Resistant Advanced Melanoma

Rechallenge With Nivolumab After Vemurafenib Treatment of Initially Nivolumab-Resistant Advanced... This case report describes a patient with advanced melanoma initially resistant to nivolumab therapy, treated with vemurafenib, and then rechallenged with nivolumab after development of vemurafenib-related adverse effects. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Rechallenge With Nivolumab After Vemurafenib Treatment of Initially Nivolumab-Resistant Advanced Melanoma

Loading next page...
 
/lp/american-medical-association/rechallenge-with-nivolumab-after-vemurafenib-treatment-of-initially-ysKpKJup6N

References (6)

Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/jamadermatol.2017.6400
Publisher site
See Article on Publisher Site

Abstract

This case report describes a patient with advanced melanoma initially resistant to nivolumab therapy, treated with vemurafenib, and then rechallenged with nivolumab after development of vemurafenib-related adverse effects.

Journal

JAMA DermatologyAmerican Medical Association

Published: May 28, 2018

There are no references for this article.